PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
Front Oncol. 2021 Mar 25;11:644737. doi: 10.3389/fonc.2021.644737. eCollection 2021.
Front Oncol. 2021.
PMID: 33842357
Free PMC article.
Review.